• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

中国药物评价 ›› 2024, Vol. 41 ›› Issue (2): 88-92.

• 医疗器械审评科学 • 上一篇    下一篇

我国增材制造个性化医疗器械上市前监管现状和挑战

 闵玥, 史新立   

  1. 国家药品监督管理局医疗器械技术审评中心, 北京 100081
  • 收稿日期:2024-04-22 修回日期:2024-05-06 出版日期:2024-04-28 发布日期:2024-04-28
  • 基金资助:
    国家重点研发计划(2017YFB1104105)

Current Pre-Market Regulatory Situation and Challenges of Personalized and Additive-Manufactured Implant Devices in China

  1. Center for Medical Device evaluation, NMPA, Beijing 100081, China
  • Received:2024-04-22 Revised:2024-05-06 Online:2024-04-28 Published:2024-04-28

摘要: 增材制造个性化医疗器械是当前研究热门和监管科学研究重点。本文全面梳理了当前我国增材制造个性化医疗器械的上市前监管现状,包括产品定义、监管模式和分类管理等法规要求,指导原则和标准体系建设等内容。同时,结合国际前沿的监管研究和技术进展,提出当前监管科学研究面临的新问题和挑战,为相关人员提供参考。

关键词: font-size:medium, ">增材制造;个性化医疗器械;上市前监管

Abstract: Additive manufacturing of personalized medical devices is hot study area and one of the key points of regulatory scientific research. This article comprehensively reviews the current regulatory status of personalized medical devices in additive manufacturing in China, including regulatory requirements such as definition, regulatory mode and classification management, technical guidance and standard system. In addition, combined with the International regulatory research and technology development, this paper puts forward the new problems and challenges to provide reference for relevant personnel.

Key words: font-size:medium, ">Additive manufacture;Personalized medical devices;Pre-market administration

中图分类号: